Advertisement

Topics

GuillainBarr Syndrome GBS - Biotech, Pharma and Life Science Channel

01:58 EDT 19th July 2018 | BioPortfolio

PubMed Articles [4687 Associated PubMed Articles listed on BioPortfolio]

Colonic fermentation of polyphenols from Chilean currants (Ribes spp.) and its effect on antioxidant capacity and metabolic syndrome-associated enzymes.

The Chilean wild currants Ribes magellanicum and R. punctatum are a good source of polyphenols. Polyphenolic-enriched extracts (PEEs) from both species were submitted to in vitro colonic fermentation ...

Low-density lipoprotein cholesterol target achievement in patients surviving an acute coronary syndrome in Hong Kong and Taiwan - findings from the Dyslipidemia International Study II.

Individuals are at increased risk for cardiovascular events following an acute coronary syndrome (ACS). Effective management of hyperlipidemia, an associated risk factor, is essential for improving ou...

Reply: Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome.

Nardilysin: A potential biomarker for the early diagnosis of acute coronary syndrome.

Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis.

Guillain-Barré syndrome (GBS) is an immune-mediated acute disorder of the peripheral nervous system. Despite treatment, there is an associated mortality and severe disability in 9 to 17% of the cases...

Do we have to rethink Complex Regional Pain Syndrome?

A case of Nablus mask-like facial syndrome with autism spectrum disorders.

Behçet syndrome: effects of Pycnogenol® supplementation during regression phases.

The aim of this comparative registry study was to evaluate the supplementation with Pycnogenol® in subjects with Behçet syndrome (BS) with symptoms impairing their quality of life despite being in a...

Expansion Thoracoplasty in Rabbit Model: Effect of Timing on Preserving Pulmonary Growth and Correcting Spine Deformity.

In a treatment-control animal study expansion thoracoplasty (ET) was performed in a juvenile rabbit model of thoracic insufficiency syndrome (TIS) and benefits to thoracic development and respiratory ...

Twin-to-twin-transfusion syndrome: from amniodrainage to laser.

News Articles [1148 Associated News Articles listed on BioPortfolio]

Use of nicotine during pregnancy may increase risk of sudden infant death syndrome

Nicotine exposure during pregnancy, whether from smoking cigarettes, or nicotine patches and e-cigarettes, increases risk of sudden infant death syndrome -- sometimes known as 'cot death' -- according...

ConSynance’s CSTI-300 Irritable Bowel Syndrome Data Presented at International Scientific Meeting

ConSynance Therapeutics, Inc. announced today that collaborator Dr. Nicholas Barnes presented data at the International Society for Serotonin Research in Cork, Ireland showing the...

SUSU scientists find alternative method to treat post-traumatic stress disorder syndrome

In spite of high level of modern medicine development many problems of this sphere are not solved till the present.

The Latest on Chronic Fatigue Syndrome

WEDNESDAY, July 18, 2018 -- Illnesses that lack exact testing methods can be difficult to diagnose, treat and live with, both physically and emotionally. Chronic fatigue syndrome, or CFS, is one such ...

Using Multilocus Sequence Typing for Surveillance and Discovery of Borrelia Species

Broad polymerase chain reaction screening followed by multilocus sequence typing is a useful method to understand the geographic distribution of Borrelia species causing human disease. Candidatus B. j...

Small molecule inhibition of RAS/MAPK signaling ameliorates developmental pathologies of Kabuki Syndrome

Global Myelodysplastic Syndrome Therapeutics Market 2018-2022 | Need for Cost-effective Stem Cell Therapies to Drive Growth | Technavio

The global myelodysplastic syndrome therapeutics market 2018-2022 is expected to post a CAGR of close to 3% during the forecast period, according to the latest market research rep...

Regimen Shows Potential for Reducing TLS Risk in CLL

Kerry Rogers, MD, discusses the feasibility of a new treatment for tumor lysis syndrome and what research still needs to be done with these agents in chronic lymphocytic leukemia.

Early Renal Replacement Therapy in Acute Respiratory Distress Syndrome and Sepsis?

Early RRT did not lower mortality in patients with acute kidney injury associated with ARDS or septic shock.

Humanetics Awarded Patent for Oral Drug to Protect Warfighters and First Responders from Radiation Exposure

Patent protects the use of Humanetics’ lead drug candidate, BIO 300, to prevent Acute Radiation Syndrome (ARS) Minneapolis-based Humanetics Corporation (Humanetics) has been...

Events [0 Results]

None

Companies [70 Associated Companies listed on BioPortfolio]

ConSynance Therapeutics, Inc.

ConSynance Therapeutics is a clinical-stage drug development company based in Rensselaer, New York. The company’s pipeline includes innovative treatments for nonalcoholic ste...

PellePharm

Founded by world leaders in hedgehog signaling, PellePharm, a BridgeBio company, is committed to targeting rare genetic dermatological conditions, including Gorlin Syndrome and Ba...

ConSynance Therapeutics Inc.

ConSynance Therapeutics is a clinical-stage drug development company based in Rensselaer, New York. ConSynance’s pipeline includes innovative treatments for NASH, the orphan ...

Tetra Discovery Partners Inc.

Tetra Discovery Partners is a clinical stage biotechnology company developing a portfolio of therapeutic products that will bring clarity of thought to people suffering from Alzhe...

Jaguar Health, Inc.

Jaguar Health, Inc. is a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human pre...

Progenity Inc.

Progenity is a biotechnology company with a market-leading presence in Women’s Health molecular testing and a pipeline of proprietary tests and therapeutic applications under...

Syros Pharmaceuticals, Inc.

Syros Pharmaceuticals is pioneering the understanding of the non-coding region of the genome to advance a new wave of medicines that control expression of disease-driving genes. S...

Sancilio Pharmaceuticals Company, Inc.

Sancilio Pharmaceuticals Company, Inc. (SPCI) is a fully integrated, specialty pharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical produ...

Agilis Biotherapeutics and GTRI

Agilis is advancing innovative gene therapies designed to provide long-term efficacy for patients with debilitating, often fatal, rare genetic diseases that affect the central ner...

PAVmed Inc.

PAVmed Inc. (Nasdaq: PAVM, PAVMW) is a highly differentiated, multi-product medical device company employing a unique business model designed to advance products from concept to c...

Clinical Trials [3742 Associated Clinical Trials listed on BioPortfolio]

Therapeutic Plasma Exchange Adsorption Diafiltration

The purpose of this study is to evaluate the efficacy of coupled therapeutic plasma exchange adsorption diafiltration (PEAF )for treating septic shock with multiple organ dysfunction syndr...

Reduce Bolus Injection of Bivalirudin

There are fewer studies on the bleeding risk of the currently administered bivalirudin bolus injection dose and the safety of bivalirudin in patients with CKD. A non-inferiority, randomize...

Prospective Metabolic Indicator Study

The aim of this study was to assess the impact of a physician-supervised non-surgical medical weight management program on prevalence of metabolic syndrome and to examine the relationship ...

Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine

The main purpose of this study is to determine the safe and efficacy of APR-246 in combination with azacitidine as well as to see complete remission of this patients

Intracoronary Features in the Prognosis of Endothelial Dysfunction and MACES in Population With Acute Coronary Syndrome

Coronary Artery Disease (CAD) is common in Mexico, while morbidity and mortality is high. Drug therapy can relieve angina pain and stabilize plaque, but it is not able to re-flow a coronar...

Physiotherapy or Fasciotomy as Treatment for Chronic Exertional Compartment Syndrome in the Lower Leg?

It is hypothesized that physiotherapy including a change in running landing pattern and surgical fasciotomy are equally good as treatment options for chronic exertional compartment syndrom...

Post-discharge Outcomes of Pediatric Acute Respiratory Distress Syndrome

In this study, the investigators aim to better characterize the outcomes of pediatric acute respiratory distress syndrome (PARDS) survivors, to examine whether subgroups of children with P...

Frailty Prevention Program to Prevent Frailty Among Older African Americans

Between 20-60% of older adults experience frailty as they age. Frailty is a clinical state of increased vulnerability resulting from aging-associated declines in biological reserve across ...

Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis

This is a prospective, multicenter cohort observational; study to compare treatment outcomes in patients admitted to the hospital with Stevens-Johnsons Syndrome/Toxic Epidermolysis, aiming...

Effects of Oral Inositol Supplementation on Obstetrics Outcomes in PCOS Women

Polycystic ovarian syndrome (PCOS) is a heterogeneous, multifaceted and complex disorder characterized by insulin resistance (IR), hyperinsulinemia, and hyperandrogenism leading ovarian di...

Videos

None available.

Medical and Biotech [MESH] Definitions

Condition with a variable constellation of phenotypes due to deletion polymorphisms at chromosome location 22q11. It encompasses several syndromes with overlapping abnormalities including the DIGEORGE SYNDROME, VELOCARDIOFACIAL SYNDROME, and CONOTRUNCAL AMOMALY FACE SYNDROME. In addition, variable developmental problems and schizoid features are also associated with this syndrome. (From BMC Med Genet. 2009 Feb 25;10:16) Not all deletions at 22q11 result in the 22q11deletion syndrome.

Rare congenital disorder with multiple anomalies including: characteristic dysmorphic craniofacial features, musculoskeletal abnormalities, neurocognitive delay, and high prevalence of cancer. Germline mutations in H-Ras protein can cause Costello syndrome. Costello syndrome shows early phenotypic overlap with other disorders that involve MAP KINASE SIGNALING SYSTEM (e.g., NOONAN SYNDROME and cardiofaciocutaneous syndrome).

An autosomal dominant aneurysm with multisystem abnormalities caused by increased TGF-BETA signaling due to mutations in type I or II of TGF-BETA RECEPTOR. Additional craniofacial features include CLEFT PALATE; CRANIOSYNOSTOSIS; HYPERTELORISM; or bifid uvula. Phenotypes closely resemble MARFAN SYNDROME; Marfanoid craniosynostosis syndrome (Shprintzen-Goldberg syndrome); and EHLERS-DANLOS SYNDROME.

Birth defect that results in a partial or complete absence of the CORPUS CALLOSUM. It may be isolated or a part of a syndrome (e.g., AICARDI'S SYNDROME; ACROCALLOSAL SYNDROME; ANDERMANN SYNDROME; and HOLOPROSENCEPHALY). Clinical manifestations include neuromotor skill impairment and INTELLECTUAL DISABILITY of variable severity.

A syndrome of DYSPHAGIA with IRON-DEFICIENCY ANEMIA that is due to congenital anomalies in the ESOPHAGUS (such as cervical esophageal webs). It is known as Patterson-Kelly syndrome in the United Kingdom.

Advertisement
Quick Search
Advertisement
Advertisement

 
review and buy GuillainBarr Syndrome GBS market research data and corporate reports here

Channels Quicklinks